Group A (n = 23) | Group R (n = 10) | Group AR (n = 4) | p-value | ||||
Gender (Male) | 19 | 7 | 2 | 0.33 | |||
Age (years) | 65.9 ± 12.6 | 68.4 ± 7.9 | 63.3 ± 14.3 | 0.74 | |||
BSA (m2) | 1.62 ± 0.18 | 1.62 ± 0.12 | 1.61 ± 0.12 | 1.00 | |||
NYHA | 2.1 ± 0.5 | 2.0 ± 0 | 1.8 ± 0.5 | 0.37 | |||
MR grade | 3.9 ± 0.3 | 3.7 ± 0.5 | 4.0 ± 0 | 0.26 | |||
LVEF (%) | 61.5 ± 9.1 | 64.6 ± 9.4 | 69.2 ± 1.7 | 0.24 | |||
HT | 11 | 6 | 3 | 0.55 | |||
CAD | 2 | 4 | 0 | 0.05 | |||
CVD | 2 | 1 | 0 | 0.81 | |||
PAD | 1 | 1 | 0 | 0.71 | |||
CKD | 7 | 4 | 1 | 0.82 | |||
Respiratory dysfunction | 7 | 1 | 0 | 0.23 | |||
PAF | 4 | 1 | 0 | 0.60 | |||
CAF | 6 | 4 | 1 | 0.71 | |||